George Adams, B.A.Sc., M.A.Sc., Ph.D., ICD.D

Dr. Adams is a scientist and serial entrepreneur and financier. His currently previous position was CEO of Amorfix Life Sciences (TSX:AMF) from 2005-2010.
He continues as Chairman of Sernova Corp (TSXV:SVA). He was awarded a World Economic Foundation Technology Pioneer for 2007 and TBI Company of the year in 2009.
Dr. Adams was the President and CEO of the UT Innovations Foundation from 1999 until 2004.
Prior to this, he held research and executive positions with Boston Scientific Inc, Pfizer Inc, Corvita Canada Inc., University of Ottawa and Canadian Red Cross, Blood Transfusion Service.
He has been instrumental in founding over 30 companies who have raised $100 million and has been a Director of 10 venture capital funds and 10 start-up companies.
Dr. Adams has 124 scientific publications and is a reviewer for major scientific journals, federal granting agencies and Centres of Excellence.

top

Amol Karnick - Vice President, Sales and Business Development

More than eighteen years of medical imaging experience.
Seven years experience at GE Healthcare in various roles, including mergers and acquisitions where he helped drive $150 million in imaging sales as well as integrating 4 companies.
Chief Operating Officer for Sentinelle Medical Incorporated - where he was responsible for Engineering, Service, Manufacturing and Regulatory affairs.
General Manager at Ultrasonix Medical Corporation, where he created and led the service team and directly grew sales through business development.
Global expertise and experience working with multiple cultures around the world.
Masters in Electrical Engineering (ultrasound) from McGill University.

top

Florence H. Sheehan, M.D. - Founder, Chief Scientist

Professor of Medicine/Cardiology at the University of Washington.
Twenty-seven years experience in cardiac image analysis.
Developed the centerline method for measuring regional ventricular function.
Directed the development of the CenterLine wall motion method. This method carries an FDA 510(k) and has been licensed to 15 companies, bringing in $1,466,326 to date.
Holds 7 patents in the field of quantitative cardiac imaging.
Director of the Cardiovascular Research and Training Center at the UW, which has served as the Core Laboratory for image analysis to over a dozen multi-center clinical trials.

top

John Gebhart - Vice President, CFO

Twenty-seven years of operating expertise in building and financing emerging service and technology companies.
CEO and Chairman of Carewise, Inc., a pioneer in telephone nurse counseling and demand management.
Mr. Gebhart managed all aspects of the successful initial public offering of Access Health, Inc., and led the company’s investor relations efforts during a five-fold increase in the company’s market value.
During his career Mr. Gebhart has managed public, private, and partnership financings in excess of $150 million.
Mr. Gebhart received his MBA from Pepperdine University and his Bachelors degree in Accounting from Widener University. He started his career with Arthur Young & Company.

top

Scott Ashley - Vice President, Research and Development

Twenty-six years of core operating system software development, project management, first-line, second-line, and director experience.
Director of software development for HP Integrity NonStop NS16000 Server. Managed a team of over 80 software developers; operating systems, low-level millicode, compilers, debuggers, QA groups. Either directly controlled or influenced an annual division-wide budget of more than $10M.
Key driving force across the Tandem NonStop Division introducing quality improvement activities that reduced defect introduction rates and increased schedule accuracy.
Second line management responsibility for Tandem NonStop device driver development group, managing a team of 35 software developers; device driver, device diagnostics, device software quality assurance groups. Responsible for the device driver level changes across those groups for the support of the Tandem NonStop S7000 and S70000 products.
Manager Tandem device driver group. Responsible for rebuilding a software development group from 1 person to 8 people. Managed all software development activities supporting disk, tape, optical disk and generic SCSI devices. Drove major quality improvement project to re-write the key Tandem NonStop device driver software.

top

Eyal Schwartz – Chief Architect

Sixteen years experience leading various Software Development projects.
Experienced software development leader at Microsoft Corporation in the Windows, MSN, and Entertainment divisions.
Lead design and development of wide array of technologies including secure distributed systems, advanced user interfaces, client/server and web technologies.
Owner of ten U.S. patents.
M.S. in Computer Science from Georgia Institute of Technology

top

Board of Directors

Treuman Katz - Chairman; Chairman of Nominating and Corporate Governance Committee.

Mr. Katz is currently the President Emeritus of the Seattle Children's Hospital & Regional Medical Center ("Seattle Children's"), after serving as its President and Chief Executive Officer from 1979 to October 2005. Under his leadership, Seattle Children's became one of America's top five children's hospitals with assets of over US$1 billion and an annual budget of more than US$500 million. Mr. Katz led the strategic planning process that resulted in the creation and establishment of the Seattle Cancer Care Alliance; Children's University Medical Group (CUMG), a major joint venture between Children's Health Care System and the University of Washington School of Medicine; Child Health Corporation of America, a national venture of 42 hospital organizations; Airlift Northwest, a consortium organized to transport patients throughout the Northwest by fixed-wing and helicopter; and a multi-organ transplant program established at Seattle Children's for heart, liver, small bowel, and bone marrow. Prior to his tenure at Seattle Children's, Mr. Katz served as a senior executive at Cedars-Sinai Medical Center in Los Angeles. Mr. Katz has a Masters degree in Science from the University of California at Berkeley, California and an MBA from George Washington University in Washington D.C.

George Adams - Director; President and Chief Executive Officer; Member of Nominating and Corporate Governance Committee.

See above for Mr. Adams' bio.

Danny Dalla-Longa – Director; Chairman of Audit Committee; Member of Compensation Committee. (Former CEO and Chairman of Luca Capital Inc.)

Mr. Dalla-Longa holds a Bachelor of Commerce from the University of Calgary, Chartered Business Valuation degree, as well a two valuation degrees from the U.C. and also is a Chartered Accountant. During the years of 1993 to 1997, Mr. Dalla-Longa served as an MLA as the energy critic in the Alberta Legislature. Prior to 1993 he was a partner in corporate and business valuations for 18 years with the international accounting firm, KPMG. Mr Dalla-Longa has had extensive experience with public companies in a number of different industry sectors.

top

Brad Harlow – Director; Chairman of Compensation Committee.

Mr. Harlow is the Managing Partner of B. Harlow & Associates, LLC which advises med-tech companies for financing, Mergers & Acquisitions and buyouts. His group has led over $200 million in financing, asset/division sales and new technology investments over the last 10 years. Mr. Harlow also serves as the Chairman of Commerce Bridge Company LLC, a private business-to business lending company and as the CEO of PhysioSonics, a neuromonitoring start up using ultrasound technology for monitoring blood flow in the brain.

Previously, he served as Senior Vice President of publicly listed Data Critical, which was acquired by GE Medical in 2002. Data Critical’s systems enhanced the quality, cost, efficiency, safety and outcome of healthcare. Brad began his career at ATL Ultrasound and Spacelabs Medical. Brad received a BS in Accounting from Oregon State University, an MBA from Seattle University and has taught executive programs in Finance at the USC School of Business.

top

Don Black – Director; Member of Audit Committee; Member of Compensation Committee.

Mr. Black has worked in the health care industry for over 25 years and has recently stepped down as the President of the Children's Health Corporation of America. Prior to this he was an investment banker, specializing in healthcare, at Piper, Jaffray & Hopwood, Inc. He began his career at Creighton Omaha Regional Health Care Corporation in 1976. And then held numerous positions at Excelsior Springs City Hospital and Health Midwest. His last assignment at Health Midwest was Vice President of Marketing and Development.

top

Hugh Cleland, CFA – Director; Member of Audit Committee; Member of Nominating and Corporate Governance Committee.

Mr. Cleland is an Executive VP and Portfolio Manager at Northern Rivers Funds, a BluMont Capital Company. He manages Northern Rivers' Innovation mandate, which includes the BluMont Northern Rivers Innovation RSP Fund (available on Fundserve), and the BluMont Innovation PE Strategy Fund I, which takes a private equity approach to the management of publicly traded small- and microcap technology and healthcare stocks. Mr. Cleland has managed the Innovation mandate since the inception of its first fund in May 2001. Prior to starting at Northern Rivers, Mr. Cleland worked at Interward Capital Corporation from 1998 to 2001, originally as an analyst, and later as Associate Portfolio Manager, specializing in technology equities. In 1997/1998 he was the research associate to the senior telecom services analyst at Midland Walwyn. Mr. Cleland has an Honours Bachelor of Arts degree (1997) from Harvard University and earned his CFA designation in 2001.

top

Scientific Advisory Board

Michael Gatzoulis, M.D., Ph.D., F.A.C.C., Consultant Cardiologist in Cardiology and Pediatrics at the Royal Brompton Hospital, London.
Mark Lewin, M.D., Associate Professor of Pediatrics and co-Director of the Echocardiography Laboratory at Seattle Children's Hospital and Regional Medical Center.
David Sahn, M.D., Professor of Pediatrics at Oregon Health & Science University (OHSU) in Portland, Oregon.
Robyn J Barst, M.D., Dr. Barst founded the first pediatric and adult pulmonary hypertension center in 1982 at Columbia University and served as its director until 2008. She serves as a scientific advisor to pharmaceutical companies worldwide developing novel drugs for pulmonary hypertension.
Richard Krasuski, M.D., Director of Adult Congenital Heart Disease Services at Cleveland Clinic’s Sydell and Arnold Miller Family Heart and Vascular Institute.

top

Site menu: